MedTrace Logo

A Study of the Safety and Efficacy of the VytronUS Low-Intensity Collimated Ultrasound Ablation System

NCT01900678 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2015-06-29

No results posted yet for this study

Summary

The objective of this investigation is to evaluate whether pulmonary vein isolation using the VytronUS ablation system is safe and effective acutely and at 3 months.

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

DEVICE

VytronUS Ablation System

Pulmonary vein isolation.

Sponsors & Collaborators

  • VytronUS, Inc.

    lead INDUSTRY

Principal Investigators

  • Petr Neuzil, MD, PhD · Na Homolce Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01900678 on ClinicalTrials.gov